NM_001364171.2:c.266G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001364171.2(ODAD1):​c.266G>C​(p.Arg89Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00104 in 1,551,646 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R89Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0017 ( 6 hom., cov: 31)
Exomes 𝑓: 0.00098 ( 23 hom. )

Consequence

ODAD1
NM_001364171.2 missense

Scores

1
4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.277

Publications

3 publications found
Variant links:
Genes affected
ODAD1 (HGNC:26560): (outer dynein arm docking complex subunit 1) This gene encodes a coiled-coil domain-containing protein that is a component of the outer dynein arm docking complex in cilia cells. Mutations in this gene may cause primary ciliary dyskinesia 20. [provided by RefSeq, May 2013]
ODAD1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 20
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0039197803).
BP6
Variant 19-48318481-C-G is Benign according to our data. Variant chr19-48318481-C-G is described in ClinVar as Benign. ClinVar VariationId is 241874.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00168 (256/152282) while in subpopulation EAS AF = 0.0471 (244/5182). AF 95% confidence interval is 0.0422. There are 6 homozygotes in GnomAd4. There are 141 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ODAD1NM_001364171.2 linkc.266G>C p.Arg89Pro missense_variant Exon 5 of 16 ENST00000674294.1 NP_001351100.1
ODAD1NM_144577.4 linkc.155G>C p.Arg52Pro missense_variant Exon 3 of 14 NP_653178.3 Q96M63-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ODAD1ENST00000674294.1 linkc.266G>C p.Arg89Pro missense_variant Exon 5 of 16 NM_001364171.2 ENSP00000501363.1 A0A6I8PTZ2

Frequencies

GnomAD3 genomes
AF:
0.00168
AC:
256
AN:
152164
Hom.:
6
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0470
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00395
AC:
615
AN:
155732
AF XY:
0.00380
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0532
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000664
Gnomad OTH exome
AF:
0.00251
GnomAD4 exome
AF:
0.000975
AC:
1365
AN:
1399364
Hom.:
23
Cov.:
31
AF XY:
0.000955
AC XY:
659
AN XY:
690192
show subpopulations
African (AFR)
AF:
0.0000633
AC:
2
AN:
31596
American (AMR)
AF:
0.000168
AC:
6
AN:
35702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25182
East Asian (EAS)
AF:
0.0315
AC:
1124
AN:
35728
South Asian (SAS)
AF:
0.000694
AC:
55
AN:
79234
European-Finnish (FIN)
AF:
0.0000203
AC:
1
AN:
49254
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5698
European-Non Finnish (NFE)
AF:
0.0000436
AC:
47
AN:
1078966
Other (OTH)
AF:
0.00224
AC:
130
AN:
58004
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.433
Heterozygous variant carriers
0
55
110
164
219
274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00168
AC:
256
AN:
152282
Hom.:
6
Cov.:
31
AF XY:
0.00189
AC XY:
141
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41556
American (AMR)
AF:
0.000196
AC:
3
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0471
AC:
244
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68026
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000171
Hom.:
0
Bravo
AF:
0.00192
ExAC
AF:
0.00203
AC:
52
Asia WGS
AF:
0.0170
AC:
60
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Sep 18, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 20 Benign:1
Dec 14, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.75
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
15
DANN
Uncertain
1.0
DEOGEN2
Benign
0.012
T
Eigen
Benign
-0.096
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.65
T
MetaRNN
Benign
0.0039
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
-0.28
PrimateAI
Benign
0.33
T
PROVEAN
Uncertain
-3.1
D
REVEL
Benign
0.14
Sift
Benign
0.053
T
Sift4G
Uncertain
0.031
D
Polyphen
1.0
D
Vest4
0.36
MVP
0.39
MPC
0.92
ClinPred
0.067
T
GERP RS
2.3
Varity_R
0.32
gMVP
0.77
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58966182; hg19: chr19-48821738; API